More efforts to explore the association between cirrhosis and COVID-19 mortality, and the association between NAFLD and severe COVID-19.

Li, Zheng; Hu, Yue; Li, Qiang

Li, Zheng; Hu, Yue; Li, Qiang.

Li Z; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China; Lanzhou Heavy Ion Hospital, Lanzhou, China.
Hu Y; Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Li Q; Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China; Lanzhou Heavy Ion Hospital, Lanzhou, China. Electronic address: liqiang@impcas.ac.cn.

J Hepatol ; 78(5): e178-e180, 2023 05.

Article in English | MEDLINE | ID: covidwho-2268948

Subject(s)

COVID-19; Non-alcoholic Fatty Liver Disease; Humans; Non-alcoholic Fatty Liver Disease/complications; Non-alcoholic Fatty Liver Disease/epidemiology; COVID-19/complications; Liver Cirrhosis/complications; Liver Cirrhosis/epidemiology; Fibrosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2023 Document Type: Article Affiliation country: J.jhep.2022.11.024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google